An approval for the first drug for a rare lipid storage disease, some FDA workers rehired, and other biotech news of the day ...
Type C Meeting Requested to Accelerate XRx-026 for Gout to NDA ● CALGARY, Alberta, Feb. 24, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc.
Political and business leaders are rethinking AI—as not just a technology to regulate but as a force to accelerate. Medicine ...
Sotagliflozin significantly reduces heart attacks and strokes in high-risk patients with diabetes and kidney disease, ...
Lupin and its alliance partner Natco received clearance from the FDA for bosentan tablets for oral suspension, 32 mg, which ...
Millions of Americans take proton pump inhibitors (PPIs) like Prilosec, Nexium, and Prevacid to manage acid reflux, heartburn, and gastroesophageal reflux disease (GERD).
An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...
The results showed that people who took sotagliflozin had a 23% lower risk of heart attacks, strokes, and death from ...
INNOVATE Corp. surged 150% after its subsidiary MediBeacon received FDA approval for its TGFR system. See why I rate VATE ...
A team of researchers, led by one of Indian origin, has found that a drug recently approved by the US Food and Drug ...
A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.
President Donald Trump has signed a new executive order to establish a Make America Healthy Again Commission, just hours ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results